A Newborn with Gastric Hemangioma Treated Using Propranolol

Area of Science:

• Pediatric Gastroenterology
• Vascular Anomalies

Background:

• Gastric hemangiomas are rare benign vascular tumors.
• They can cause severe gastrointestinal bleeding, particularly in neonates.
• Surgical intervention is the traditional treatment for gastric hemangiomas.

Observation:

• A neonate presented with severe gastrointestinal bleeding and melena.
• Esophagogastroduodenoscopy confirmed a gastric hemangioma.
• Initial treatment with antacids and somatostatin reduced hemorrhage.

Findings:

• Propranolol treatment was initiated, leading to significant hemangioma regression within three weeks.
• Endoscopic evaluation confirmed tumor shrinkage.
• The neonate experienced no recurrence of gastrointestinal bleeding or adverse effects from propranolol.

Implications:

• Propranolol may offer a viable non-surgical therapeutic option for gastric hemangiomas.
• This approach could reduce the need for invasive surgery in affected neonates.
• Further research is warranted to establish propranolol's efficacy and safety profile for this condition.